- Home
- INCY vs PKG Comparison
INCY vs PKG Comparison
Compare INCY & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCY
- PKG
- Stock Information
- Founded
- INCY 1991
- PKG 1867
- Country
- INCY United States
- PKG United States
- Employees
- INCY N/A
- PKG N/A
- Industry
- INCY Biotechnology: Commercial Physical & Biological Resarch
- PKG Containers/Packaging
- Sector
- INCY Health Care
- PKG Consumer Discretionary
- Exchange
- INCY Nasdaq
- PKG Nasdaq
- Market Cap
- INCY 17.0B
- PKG 18.5B
- IPO Year
- INCY 1993
- PKG 2000
- Fundamental
- Price
- INCY $91.48
- PKG $204.73
- Analyst Decision
- INCY Buy
- PKG Buy
- Analyst Count
- INCY 19
- PKG 7
- Target Price
- INCY $81.73
- PKG $233.00
- AVG Volume (30 Days)
- INCY 1.7M
- PKG 716.7K
- Earning Date
- INCY 10-28-2025
- PKG 10-22-2025
- Dividend Yield
- INCY N/A
- PKG 2.44%
- EPS Growth
- INCY 900.04
- PKG 25.72
- EPS
- INCY 4.37
- PKG 10.02
- Revenue
- INCY $4,584,996,000.00
- PKG $8,640,800,000.00
- Revenue This Year
- INCY $16.41
- PKG $9.11
- Revenue Next Year
- INCY $10.86
- PKG $12.38
- P/E Ratio
- INCY $20.90
- PKG $20.44
- Revenue Growth
- INCY 18.87
- PKG 8.98
- 52 Week Low
- INCY $53.56
- PKG $172.72
- 52 Week High
- INCY $92.86
- PKG $250.82
- Technical
- Relative Strength Index (RSI)
- INCY 67.77
- PKG 42.53
- Support Level
- INCY $84.38
- PKG $198.27
- Resistance Level
- INCY $92.86
- PKG $212.30
- Average True Range (ATR)
- INCY 2.44
- PKG 5.95
- MACD
- INCY 0.35
- PKG -0.36
- Stochastic Oscillator
- INCY 86.26
- PKG 36.91
About INCY Incyte Corp.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.